What is CareDx's investment proceeds?

CareDx (CDNA) reported investment proceeds of $0 in Q4 2025.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

CareDx CDNA Investment Proceeds

Investment Proceeds at other companies

Natera, Inc.NTRA

$0-100%

NeoGenomicsNEO

$0-100%

Personalis, Inc.PSNL

$24.1M-45.5%

GeneDx HoldingsWGS

$875K—

Bio-Rad LaboratoriesBIO

$145.1M-15.2%

Opko HealthOPK

$0-100%

Other financials

Income statement

See full

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

See full

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

See full

Market cap$1.4B+32.2%

Enterprise value$1.35B+34.6%

P/S3.4×+0.3×

Profitability

See full

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

See full

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi.

The official record: CareDx’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CareDx's investment proceeds?: CareDx (CDNA) reported investment proceeds of $0 in Q4 2025.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.